Northern Trust
CLLS

Northern Trust’s Cellectis CLLS Stock Holding History

Northern Trust’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,334
Closed -$415K – 4478
2020
Q4 		$415K Sell
15,334
-446
-3% -$10K ﹤0.01% 3768
2020
Q3 		$292K Sell
15,780
-46
-0.3% -$816 ﹤0.01% 3725
2020
Q2 		$282K Sell
15,826
-1,060
-6% -$16.1K ﹤0.01% 3675
2020
Q1 		$155K Sell
16,886
-807
-5% -$12K ﹤0.01% 3731
2019
Q4 		$303K Sell
17,693
-101
-0.6% -$1.35K ﹤0.01% 3670
2019
Q3 		$185K Buy
17,794
+16
+0.1% +$215 ﹤0.01% 3784
2019
Q2 		$277K Buy
17,778
+106
+0.6% +$1.89K ﹤0.01% 3722
2019
Q1 		$324K Sell
17,672
-379
-2% -$6.72K ﹤0.01% 3656
2018
Q4 		$301K Buy
+18,051
New +$418K ﹤0.01% 3672

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIA
Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

Northern Trust's CLLS Position: Q1 2021 in Review

Northern Trust sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 15,334 shares — an estimated $415K sold.

Northern Trust first reported a position in CLLS in Q4 2018 and held it in 9 quarters. The position peaked at $415K in Q4 2020. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • Northern Trust reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • Northern Trust sold 15,334 Cellectis shares in Q1 2021, an estimated $415K.
  • Northern Trust first reported a position in Cellectis in Q4 2018 and held it in 9 quarters.
  • Northern Trust's Cellectis position peaked at $415K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Northern Trust's 13F filing for Q1 2021, filed 12 May 2021.